Skip to main content

Table 2 Classification of MRPs (n = 795) by community pharmacists

From: Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations

Classification

Sub-classification

IMeRSe

(total n = 625#) n

PharMIbridge

(total n = 170) n

Drug selection

D0 Other drug selection problem

41

18

D1 Duplication

7

0

D2 Drug interaction

12

0

D3 Wrong drug

2

2

D4 Incorrect strength

1

1

D5 Inappropriate dosage form

3

0

D6 Contraindications apparent

8

2

D7 No indication apparent

8

1

Subtotal n (%)

81 (13.1)

24 (14.1)

Over or underdose

O0 Other dose problem

21

4

O1 Prescribed dose too high

12

7

O2 Prescribed dose too low

11

3

O3 Incorrect or unclear dosing instructions

6

1

Subtotal n (%)

50 (8.0)

15 (8.8)

Compliance

C0 Other compliance problem

47

6

C1 Under-use by consumer

60

12

C2 Over-use by consumer

5

1

C3 Erratic use of medication

23

6

C4 Intentional drug misuse (incl. over-the-counter medications)

3

0

C5 Difficulty using dosage form

19

0

Subtotal n (%)

157 (25.1)

25 (14.7)

Undertreated

U0 Other undertreated indication problem

19

1

U1 Condition undertreated

65

13

U2 Condition untreated

35

3

U3 Preventative therapy required

20

1

Subtotal n (%)

139 (22.2)

18 (10.6)

Monitoring

M0 Other monitoring problem

6

5

M1 Laboratory monitoring

45

5

M2 Non-laboratory monitoring

26

11

Subtotal n (%)

77 (12.3)

21 (12.4)

Education or information

E0 Other education or information problem

36

7

E1 Patient requests drug information

10

4

E2 Patient requests disease management advice

6

3

Subtotal n (%)

52 (8.3)

14 (8.2)

Not classifiable

N0 Clinical interventions that cannot be classified

36

12

Subtotal n (%)

36 (5.8)

12 (7.1)

Toxicity or adverse reaction

T1 Toxicity, allergic reaction or adverse effect

32 (5.1)

41 (24.1)

Subtotal n (%)

32 (5.1)

41 (24.1)

  1. #Subtotal percentages do not total 100 due to rounding